Novel oral suspension addresses critical patient safety needs for hypertension treatment for patients unable to swallow tablets U.S. losartan market totals $256M annually with 71M prescriptions, ...
Scienture Holdings, Inc. (NASDAQ:SCNX) announced on Wednesday the formalization of multiple commercial group purchasing organization (GPO) agreements for its new drug, Arbli (losartan potassium) Oral ...
This study demonstrates that candesartan had greater efficacy in lowering arterial pressure when compared to losartan. Moreover, the duration of effect and response/control rates were significantly ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback